Litcius/Paper detail

Gefitinib loaded nanostructured lipid carriers: characterization, evaluation and anti-human colon cancer activity <i>in vitro</i>

Hafiz A. Makeen, Syam Mohan, Mohamed Ahmed Al-Kasim, Ibraheem M. Attafi, Rayan A. Ahmed, Nabeel Kashan Syed, Muhammad H. Sultan, Mohammed Albratty, Hassan A. Alhazmi, Mohammed M. Safhi, Raisuddin Ali, Mohammad Intakhab Alam

2020Drug Delivery53 citationsDOIOpen Access PDF

Abstract

= 20.88 µM in HCT-116 cells). Thus NANOGEF may be considered as a potential drug delivery system for the cure of colon cancer.

Topics & Concepts

Materials scienceIn vitroGefitinibColorectal cancerCharacterization (materials science)CancerNanotechnologyCancer researchMedicineBiochemistryInternal medicineChemistryEpidermal growth factor receptorNanoparticle-Based Drug DeliveryDrug Transport and Resistance MechanismsComputational Drug Discovery Methods
Gefitinib loaded nanostructured lipid carriers: characterization, evaluation and anti-human colon cancer activity <i>in vitro</i> | Litcius